Lv61
2430 积分 2022-09-22 加入
Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917
12天前
已完结
The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases
12天前
已关闭
Drug development in IBD: from novel target identification to early clinical trials
15天前
已完结
Challenges and opportunities for IBD drug development: from early stage to regulatory approval
15天前
已关闭
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts
17天前
已完结
Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease
17天前
已完结
Treatment strategies in inflammatory bowel diseases
17天前
已关闭
Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications
25天前
已完结
Extracellular recombinant protein production from an Escherichia coli lpp deletion mutant
25天前
已完结
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage
1个月前
已完结
皖公网安备34019202002308
